Israel's Peregrine Ventures raises $115 mln medical tech fund

Peregrine said its partners include institutional and private equity investors from Israel, the United States, Europe and Australia.

A LOOK at Sheba Medical Center doctors and nurses using the latest in cutting-edge technology (photo credit: Courtesy)
A LOOK at Sheba Medical Center doctors and nurses using the latest in cutting-edge technology
(photo credit: Courtesy)

TEL AVIV - Peregrine Ventures, an Israeli venture capital fund focused on medical technology, said on Monday it closed its fourth fund, raising $115 million.
Peregrine said its partners include institutional and private equity investors from Israel, the United States, Europe and Australia.
Peregrine 4 will invest in early and late stage rounds of medical technology startups. Peregrine now has over $200 million under management, and an equal amount available for co-investment, follow-on, and late stage investments in its portfolio companies from Peregrine 1, 2, and 3.
The firm has completed 10 exits totalling more than $2 billion in cumulative value.
“There is a huge demand, and opportunity, in medical technologies in Israel and foreign investors recognise this,” Peregrine managing partner Eyal Lifschitz said.